In a TNBC murine model with specific GLS loss on tumor cells, studies revealed an elevated glutamine concentration in the tumor stroma that promoted the synthesis of glutathione, a major cellular antioxidant, in T cells to improve intra-tumoral CD8+ T cell density and functionality. This evidence concerns the gene CD8A and neoplasm.